Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Food Bioscience, Journal Year: 2025, Volume and Issue: unknown, P. 106700 - 106700
Published: April 1, 2025
Language: Английский
Citations
0Biology, Journal Year: 2024, Volume and Issue: 13(12), P. 1028 - 1028
Published: Dec. 8, 2024
Polycystic ovary syndrome (PCOS) involves complex genetic, metabolic, endocrine, and environmental factors. This study explores the effects of nicotinamide mononucleotide (NMN) in a letrozole-induced PCOS mouse model, focusing on metabolic regulation. Letrozole-induced aromatase inhibition elevated androgen reduced bile acid levels, linking liver dysfunction gut imbalance to PCOS. Letrozole-treated mice exhibited disrupted estrous cycles, ovarian congestion, testosterone. NMN intervention alleviated hyperandrogenism, abnormalities, decline but did not fully restore cycle or improve lipid profiles. Metabolomic analysis showed that partially reversed metabolism disturbances. These findings highlight NMN’s protective role reducing hyperandrogenism cyst formation. However, effective treatment should target metabolism, just symptoms, mitigate systemic effects. Bile dysregulation may play key progression warrants further investigation.
Language: Английский
Citations
0Published: Jan. 1, 2024
Language: Английский
Citations
0